Compare BAC & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAC | NVS |
|---|---|---|
| Founded | 1784 | 1895 |
| Country | United States | Switzerland |
| Employees | 213000 | 75267 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 380.6B | 286.5B |
| IPO Year | N/A | N/A |
| Metric | BAC | NVS |
|---|---|---|
| Price | $56.02 | $153.07 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 5 |
| Target Price | $60.34 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 34.5M | 1.5M |
| Earning Date | 04-15-2026 | 04-28-2026 |
| Dividend Yield | 2.12% | ★ 2.16% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.11 | $2.30 |
| Revenue Next Year | $5.80 | $5.27 |
| P/E Ratio | ★ $14.01 | $23.13 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.06 | $112.34 |
| 52 Week High | $57.55 | $170.46 |
| Indicator | BAC | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 71.07 | 58.07 |
| Support Level | $51.20 | $149.49 |
| Resistance Level | $57.21 | $157.63 |
| Average True Range (ATR) | 1.12 | 2.03 |
| MACD | 0.41 | 0.56 |
| Stochastic Oscillator | 95.52 | 87.91 |
Bank of America is a formidable financial titan with a $3.5 trillion balance sheet and a cornerstone of the American economy, holding the second-largest deposit market share in the United States. While the firm has maintained its stronghold among middle-market and retail clientele domestically, Bank of America has continued to hold its own on the global stage, as evidenced by its fourth-largest global trading operation and an investment banking division that regularly finishes in the top four in global league tables. The firm is organized across four segments: consumer banking, global wealth and investment management, global banking, and global markets.
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.